Welcome to our dedicated page for Zions Bancorporation N A SEC filings (Ticker: ZION), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Zions Bancorporation, N.A. (NASDAQ: ZION) SEC filings page on Stock Titan provides access to the bank’s regulatory disclosures, including current reports on Form 8-K and other key documents filed with the U.S. Securities and Exchange Commission. Zions Bancorporation, N.A. is a national banking association organized in the United States, with Commission File Number 001-12307, and it files under the Securities Exchange Act of 1934.
Recent Form 8-K filings from Zions Bancorporation, N.A. include reports of quarterly financial results under Item 2.02, where the bank furnishes earnings press releases and supplemental presentations as exhibits. These filings describe net earnings, balance sheet metrics, and commentary from management, and they are explicitly identified as being furnished rather than filed for certain liability purposes. Other 8-K filings contain detailed forward-looking statement disclosures, outlining risks related to loan and securities portfolios, deposit composition, economic and political conditions, interest rate changes, regulatory developments, technology and cybersecurity, and reputational factors.
Through Stock Titan, users can review these filings alongside AI-powered summaries that explain the main points of lengthy documents such as earnings releases and risk disclosures. Real-time updates from the SEC’s EDGAR system ensure that new 8-Ks and other forms appear promptly, while AI-generated overviews help readers interpret complex language and identify key themes.
Investors can also use this page to track information relevant to Zions Bancorporation, N.A.’s capital structure, including references to its NASDAQ-listed common stock (ZION) and NYSE-listed Series A preferred shares (ZIONP). As additional forms such as annual reports on Form 10-K, quarterly reports on Form 10-Q, and insider transaction reports on Form 4 are filed, they can be accessed here with AI assistance to highlight significant developments, governance items, and risk factors.
Paul E. Burdiss filed a Rule 144 notice to sell 16,085 shares of common stock through Fidelity Brokerage Services, with an aggregate market value of $1,029,440.00, on or about 02/05/2026 on the NASDAQ.
The shares to be sold were acquired on 02/05/2026 via an option granted on 02/10/2020 by the issuer and paid for in cash. Over the prior three months, Burdiss sold 11,663 common shares on 02/03/2026 for gross proceeds of $721,751.01. The filing also notes total shares outstanding of 147,641,034.
Zions Bancorporation, National Association executive Rena A. Miller, Executive VP & General Counsel, reported multiple equity transactions in company common stock. On February 3, 2026, she exercised stock options covering 489 shares at $45.65 and 509 shares at $48.65, converting them into common stock.
On the same date, Miller disposed of 362 shares at $61.89 and 402 shares at $61.83, with all holdings reported as directly owned. After these transactions, she held 10,082 shares of Zions common stock. The underlying option grants have a graded vesting schedule, meaning different tranches become exercisable at different times.
Zions Bancorporation, National Association reported insider transactions by President & COO Scott J. McLean on February 2, 2026. McLean exercised multiple stock options for 1,955 and 11,665 shares at $51.17, and 2,190 and 17,315 shares at $45.65.
He then sold 11,665 shares at a weighted average price of $61.143 and 17,315 shares at $61.147, both executed in multiple trades within narrow price ranges. After these exercises and sales, McLean directly owned 84,440 shares of Zions common stock.
Zions Bancorporation executive vice president Derek Steward reported an option exercise and related stock sale. On February 2, 2026, he exercised a stock option for 769 shares of common stock at $51.17 per share and then sold 769 shares at $60.46 per share. After these transactions, he directly owned 14,307 shares of Zions Bancorporation common stock. The exercised option carried a graded vesting schedule, with exercisability varying by tranche.
Eric Ellingsen, Executive VP and Division CEO of Zions Bancorporation, reported an option exercise and matching share sale. On February 2, 2026, he exercised stock options for 1,519 shares of common stock at $51.17 per share and acquired those shares.
On the same date, he sold 1,519 common shares at $61.265 per share, leaving him with 40,361 shares of common stock held directly after the transactions. The exercised stock option, with a graded vesting schedule, covered 1,519 underlying shares and now shows zero remaining derivative securities.
Zions Bancorporation insider plans to sell 11,663 common shares under Rule 144. The shares are to be sold through Fidelity Brokerage Services on NASDAQ, with an aggregate market value of $721,751.09.
The seller acquired these 11,663 shares on 02/03/2026 by exercising stock options originally granted on 03/01/2019 and paid the exercise price in cash. The filing notes that 147,641,034 shares of this class were outstanding, providing context for the planned sale size.
A holder of ZION common stock has filed a Rule 144 notice to sell 1,519 shares through Fidelity Brokerage Services LLC on 02/02/2026 on the NASDAQ market. The filing lists an aggregate market value of 93,061.54 for this planned sale.
The securities were acquired as common stock on 02/02/2026 following an option granted on 03/01/2019, with the purchase price paid in cash. The notice indicates that common shares outstanding were 147,641,034 at the time referenced in the form.
A shareholder associated with ticker ZION has filed a Rule 144 notice to sell up to 28,980 shares of common stock through Fidelity Brokerage Services on the NASDAQ, with an indicated aggregate market value of $1,771,993.35. The filing notes that 147,641,034 shares of this class were outstanding at the time of the notice and that sales are expected to begin around 02/02/2026.
The shares to be sold were acquired by exercising stock options granted on 03/01/2019 and 02/10/2020, with 11,665 and 17,315 shares respectively purchased for cash on 02/02/2026. The seller certifies they are not aware of any undisclosed material adverse information about the issuer’s current or prospective operations.
A ZION shareholder filed a notice of proposed sale under Rule 144 to sell 769 shares of common stock through Fidelity Brokerage Services LLC on 02/02/2026 on the NASDAQ market, with an aggregate market value of $46,493.74.
The 769 shares were acquired on 02/02/2026 by exercising stock options originally granted on 03/01/2019, paid in cash. Shares of the same class had 147,641,034 units outstanding when this notice was prepared.
Zions Bancorporation, National Association reported its financial results for the quarter ended December 31, 2025 and disclosed this in a current report. The bank also plans to host a conference call to discuss its fourth quarter results at 5:30 p.m. Eastern Time on January 20, 2026.
The associated press release is provided as Exhibit 99.1 and an earnings presentation as Exhibit 99.2, giving more detail on the quarter’s performance. These materials are furnished, not filed, meaning they are not incorporated by reference into the bank’s securities registration statements.